Xeltis raises EUR45M series C

Xeltis AG (Zurich, Switzerland) said it raised €45 million ($52.5 million) on Nov. 15 in an oversubscribed series C financing led by an undisclosed global strategic investor, with participation from Ysios Capital and existing investors LSP, Kurma Partners and VI Partners. Other undisclosed investors also participated.

Xeltis told BioCentury the target for the series C round was €30 million...